BioPharma Credit signs $200 million loan agreement with Tarsus Pharmaceuticals
LONDON: BioPharma Credit PLC (LSE: BPCR), a leading debt investment trust specializing in life sciences, has declared a substantial financial deal with Tarsus Pharmaceuticals, Inc....
Tarsus Pharmaceuticals prices $88 million IPO on Nasdaq Global Market
LONDON: RTW Venture Fund Limited’s portfolio company Tarsus Pharmaceuticals Inc. has priced an $88 million initial public offering (IPO) and admission to trade on Nasdaq...